Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human germline mutation in the factor IX gene.

S S Sommer1, W A Scaringe, K A Hill

  • 1Department of Molecular Genetics, Beckman Research Institute, 1450 East Duarte Road, City of Hope, Duarte, CA 91010-0269, USA. sommerlab@coh.org

Mutation Research
|October 12, 2001
PubMed
Summary

Factor IX germline mutations in hemophilia B provide insights into human mutation rates. Most mutations are endogenous, with patterns consistent across diverse populations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factor IX inhibitors and anaphylaxis in haemophilia B.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Factor IX inhibitors and anaphylaxis in hemophilia B.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Development of a novel method for detection of Clostridium difficile using HS-SPME-GC-MS.

Journal of applied microbiology·2013
Same author

Comparison of two selective media for the recovery of Clostridium difficile from environmental surfaces.

The Journal of hospital infection·2012
Same author

Long-term results of screening with magnetic resonance imaging in women with BRCA mutations.

British journal of cancer·2012
Same author

Risk factors for inhibitor formation in haemophilia: a prevalent case-control study.

Haemophilia : the official journal of the World Federation of Hemophilia·2009

Area of Science:

  • Molecular epidemiology
  • Human genetics
  • Genomics

Background:

  • Factor IX germline mutations in hemophilia B serve as a model for studying human mutations.
  • Previous research has identified mutations in a majority of target nucleotides within the factor IX gene.

Purpose of the Study:

  • To analyze the molecular epidemiology of factor IX germline mutations.
  • To estimate mutation rates and understand mutation patterns in the human genome.

Main Methods:

  • Analysis of molecular epidemiology data for factor IX mutations.
  • Estimation of mutation rates per base-pair with bias correction.
  • Investigation of mutation patterns, including sex ratio and transition types.

Main Results:

Related Experiment Videos

  • The likelihood of a factor IX missense mutation causing disease correlates with amino acid conservation.
  • Estimated 76 de novo mutations per generation per individual, with 0.3 deleterious changes.
  • Observed maternal age effect and excess of non-CpG G:C to A:T transitions.
  • Factor IX mutation patterns are consistent across diverse human populations.

Conclusions:

  • Germline mutations in the factor IX gene are primarily driven by endogenous mechanisms.
  • Mutations at splice junctions can be predicted using simple rules.
  • The study provides a comprehensive understanding of factor IX mutation dynamics and their implications for human genetics.